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Berardinelli-Seipcongenital lipodystrophy2 (BSCL2) is
caused by loss-of-functionmutations in SEIPIN, a pro-
tein implicated in both adipogenesis and lipid droplet
expansion but whose molecular function remains
obscure. Here, we identify physical and functional in-
teractions between SEIPIN and microsomal isoforms
of glycerol-3-phosphate acyltransferase (GPAT) in
multiple organisms. Compared to controls, GPAT ac-
tivity was elevated in SEIPIN-deficient cells and tis-
sues andGPAT kinetic valueswere altered. Increased
GPAT activity appears to underpin the block in adipo-
genesis and abnormal lipid dropletmorphology asso-
ciated with SEIPIN loss. Overexpression of Gpat3
blocked adipogenesis, and Gpat3 knockdown in
SEIPIN-deficient preadipocytes partially restored dif-
ferentiation.GPAToverexpression in yeast, preadipo-
cytes, and fly salivary glands also formed supersized
lipid droplets. Finally, pharmacological inhibition of
GPAT in Seipin/ mouse preadipocytes partially
restored adipogenesis. These data identify SEIPIN
as an evolutionarily conserved regulator of micro-
somal GPAT and suggest that GPAT inhibitors might
be useful for the treatment of human BSCL2 patients.
INTRODUCTION
Congenital generalized lipodystrophy (CGL; also known as Berar-
dinelli-Seip congenital lipodystrophy [BSCL]) is an autosomal1546 Cell Reports 17, 1546–1559, November 1, 2016 ª 2016 The Au
This is an open access article under the CC BY-NC-ND license (http://recessivedisordercharacterizedbyanear total lossofadipose tis-
sue, severe hypertriglyceridemia, insulin resistance, and fatty liver
(Agarwal and Garg, 2006; Magre´ et al., 2001). To date, four genes
have been linked to CGL/BSCL: 1-acylglycerol-3-phosphate-O-
acyltransferase-2 (AGPAT2)/CGL1, SEIPIN/CGL2, CAVEOLIN-1/
CGL3, and CAVIN-1/CGL4 (Fei et al., 2011a). The most severe
formofhumanCGL/BSCL iscausedby loss-of-functionmutations
inSEIPIN/BSCL2,which encodesan integralmembraneprotein of
the endoplasmic reticulum (ER) with no recognizable functional
domains (Fei et al., 2011a;Cartwright andGoodman,2012;Lundin
et al., 2006).Seipin knockout (Bscl2/) mice have severe lipodys-
trophy and insulin resistance (Cui et al., 2011; Chen et al., 2012;
Prieur et al., 2013), demonstrating an essential role for Seipin in
adipogenesis. SEIPINand its non-mammalian orthologs also con-
trol the expansion of lipid droplets (LDs). The most prominent
feature of Seipin-deficient cells is the formation of ‘‘supersized’’
LDs (Fei et al., 2008, 2011b; Szymanski et al., 2007; Tian et al.,
2011; Jiangetal., 2014;Liu et al., 2014). Thus, SEIPINhasaunique
role in regulating both systemic (adipogenesis) and cellular (LD
expansion) lipid storage.
Recent studies implicate SEIPIN and its yeast ortholog, Fld1
(also known as Sei1), in regulating phospholipid metabolism
such that the amount of phosphatidic acid (PA) is increased in
SEIPIN-deficient cells and tissues (Fei et al., 2011c; Sim et al.,
2012; Jiang et al., 2014; Wolinski et al., 2015; Han et al., 2015).
We have postulated that in preadipocytes, increased PA acts
as a peroxisome proliferator-activated receptor gamma (PPARg)
antagonist and thus blocks adipogenesis (Stapleton et al., 2011;
Fei et al., 2011a). In non-preadipocytes and yeast, PA promotes
LD expansion, likely because it is fusogenic (Fei et al., 2011c).
However, exactly how the ER-localized SEIPIN might regulate
the metabolism of phospholipids remains unknown.thor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Fld1, Ldb16, and Gat1/2 Interact in
Yeast
(A) Co-immunoprecipitation assay detecting the
interaction between overexpressed Gat1-V5 and
Fld1-FLAG in yeast lysates.
(B) Gat1-V5 and Ldb16 of endogenous level co-
immunoprecipitate with Fld1-FLAG.
(C) Using V5 antibody, overexpressed Fld1-FLAG
co-immunoprecipitates with overexpressed Gat1-
V5 and Gat2-V5 from wild-type and ldb16D yeast
lysates.
See also Figure S1 and Table S1.Through affinity isolation and tandem mass spectrometry ana-
lyses, we identified proteins that specifically co-precipitate with
Fld1-GFP in the yeast Saccharomyces cerevisiae. The most
prominent of these proteins was Gat1, a glycerol-3-phosphate
acyltransferase (GPAT). As the rate-limiting step in the synthesis
of triacylglycerol and glycerophospholipids, GPAT catalyzes the
esterification of glycerol-3-phosphate with a long-chain acyl-co-
enzyme A (acyl-CoA) to initiate the formation of PA (Cao et al.,
2012; Marr et al., 2012; Wendel et al., 2009). We found that
mammalian SEIPIN specifically interactedwith the corresponding
mammalian GPAT orthologs, GPAT3 and GPAT4. SEIPIN defi-
ciency in yeast, mammalian cells, and mouse tissues resulted in
increased GPAT activity and changes in GPAT kinetics. These
data strongly suggest that SEIPIN is an evolutionarily conserved
regulator of GPAT and that targeting GPAT may have therapeutic
potential in treating BSCL2.
RESULTS
Fld1 and Gat1 Physically Interact
To identify potential Fld1/SEIPIN-interacting proteins, we used
the native promoter of FLD1 on a low-copy plasmid in wild-pr
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GPCell Reportype or fld1D yeast cells to express GFP
alone or a functional Fld1-GFP fusion pro-
tein (Fei et al., 2008). Cell membranes
were isolated and solubilized using three
different buffer conditions, followed by
affinity purification and tandem mass
spectrometry analyses (see Experimental
Procedures).
In all three buffer/lysis conditions used,
19 proteins co-precipitated with Fld1-
GFP, but not with matrix or GFP alone
(Figure S1A; Table S1). Because our pre-
vious studies strongly suggested that
Fld1/SEIPIN regulates cellular PA content
(Fei et al., 2011c; Tian et al., 2011; Jiang
et al., 2014), we focused on the yeast
GPAT, Gat1, which catalyzes the rate-
limiting step in the de novo synthesis PA
and all glycerolipids. Tagged and overex-
pressed Fld1 and Gat1 were co-immuno-
precipitated from yeast (Figure 1A), and
this interaction was retained when bothoteins were expressed at close to endogenous levels by
ding tags at the C termini of their respective genomic loci
igure 1B). As recently reported (Wang et al., 2014), we also
entified Ldb16 as an Fld1-interacting protein in our screen (Fig-
e S1A; Table S1), and endogenous Ldb16 co-immunoprecipi-
ted with both Fld1-FLAG (Figure 1B) and Gat1 (Figure 1C).
rthermore, Fld1 and Ldb16 also co-immunoprecipitated with
t2, a second yeast GPAT that shares38% sequence identity
d 58% sequence similarity with Gat1 (Figures 1C and S1B).
wever, a yeast AGPAT homolog, Slc4, did not co-immunopre-
itate with Fld1 as well as Gat1/2 (Figure 1C). Fld1-Gat1/2
eraction was not affected in ldb16 null cells (Figure 1C), but
were not able to test whether the Ldb16 and Gat1/2 interac-
n requires Fld1, because Ldb16 is extremely unstable in the
sence of Fld1 (Wang et al., 2014; data not shown).
ammalian SEIPIN and GPAT3/4 Physically Interact
ammals express four GPAT isoforms; GPAT1 and GPAT2 are
esent on the outer mitochondrial membrane, and GPAT3 and
AT4 are present on the ER (Coleman and Mashek, 2011).
AT1 is resistant to N-ethylmaleimide (NEM), whereas the other
ATs are sensitive to NEM. SEIPIN co-immunoprecipitatedwithts 17, 1546–1559, November 1, 2016 1547
both GPAT3 and GPAT4 in 3T3L1 preadipocytes (Figure 2A). The
interaction was significantly weakened (by 50%) between
GPAT3/4 and the SEIPIN missense mutant (T78A) that causes a
human lipodystrophy (Sim et al., 2013) (Figures 2B and 2C, lane
3; Figures S1D and S1E). The C-terminal cytoplasmic region of
SEIPIN was not essential for the interaction with GPAT3 or
GPAT4, because SEIPIN C-terminal truncation mutants could still
co-precipitate a significant amount of GPAT3/4 (Figure S1C).
Importantly, overexpressed SEIPIN immunoprecipitated endoge-
nous GPAT3/4 (the commercial antibody recognizes both GPAT3
andGPAT4) (Figure 2D). As an alternative approach, inmature ad-
ipocytes, we expressed SEIPIN that was fused to the promiscu-
ous biotin ligase BirA* (Roux et al., 2012). After affinity purification
with streptavidin-conjugated beads, GPAT3/4 was detected only
in cells expressing SEIPIN-BirA*, but not SEIPIN or BirA* alone
(Figure 2E). These data indicate that GPAT3/4 in adipocytes lies
in close proximity to SEIPIN. Finally, we employed a proximity
ligation assay to further examine the SEIPIN-GPAT3/4 interaction
in vivo (So¨derberg et al., 2006). GPAT3 and GPAT4 are closer to
SEIPIN than AGPAT2 (Figure S2A) and, consistent with Fig-
ure S1C, full-length SEIPIN, but not its C terminus, interacted
strongly with GPAT3/4 (Figures S2B and S2C). To examine the ef-
fects of SEIPIN on GPAT3/4 localization, 3T3-L1 preadipocytes
were co-transfected with mCherry-SEIPIN or small hairpin RNA
(shRNA) targeting SEIPIN and GFP-tagged mouse GPAT3 or
GPAT4 and treated with fatty acids. GPAT3 primarily localizes
to LDs, and SEIPIN overexpression or knockdown had little effect
onGPAT3 localization (Figures S3A, S3B, and S3D). GPAT4 local-
izes to both ER and LDs, and SEIPIN knockdown increased the
proportion of GPAT4 on LDs (Figures S3C, S3E, and S3F).
GPAT Activity Is Increased in SEIPIN-Deficient Cells and
Tissues
To test whether SEIPIN interacts with GPAT to regulate its
activity, we measured GPAT activity in control and SEIPIN-defi-
cient yeast cells, mammalian cells, and mouse testes. In the
absence of SEIPIN, the protein expression of the microsomal
GPAT isoforms was virtually unchanged (Figures S4A–S4C).
However, GPAT-specific activity in fld1 null yeast cells was
60% higher than in controls (Figure 3A). In Seipin/ mouse
embryonic fibroblasts (MEFs), the total and microsomal GPAT
activities were twice as high as in control MEFs (Figures 3B
and S4C). Similarly, when Seipin was knocked down by 70%
in 3T3L1 preadipocytes, GPAT activity was twice as high as in
control preadipocytes (Figures 3C, S4D, and S4E), and in mouse
testes, where Seipin is normally highly expressed, total, NEM-
sensitive (GPAT2, 3&4) and NEM-resistant (GPAT1) GPAT activ-
ities were 67%, 75%, and 29% higher, respectively, in Bscl2/
testes than in controls (Figures 3D and S4F). Taken together,
these data demonstrate that SEIPIN downregulates GPAT
activity and that this regulatory role is conserved from yeast to
mammals.
SEIPIN-Deficient Cells and Tissues Had Altered GPAT
Kinetics
Next, we investigated GPAT enzyme kinetics by characterizing
the affinity of GPAT for its substrates, glycerol-3-phosphate
(glycerol-3-P) and long-chain acyl-CoA. Because acyl-CoAs1548 Cell Reports 17, 1546–1559, November 1, 2016are amphipathic and may act as detergents to disrupt mem-
branes and inhibit enzyme activity (Polokoff and Bell, 1978),
the apparent KM values for acyl-CoAs often cannot be accurately
calculated. In the absence of SEIPIN, the affinity of GPAT
for glycerol-3-P or palmitoyl-coenzyme A (palmitoyl-CoA) was
altered in MEFs, 3T3L1 cells (Figures 3E–3H and S4G–S4J),
yeast, and Bscl2/ mouse testis (Figures S4K–S4N). In each
case, GPAT-specific activity and Vmax increased (Table S2).
Increased GPAT Activity Underpins the Change in LD
Morphology in SEIPIN-Deficient Cells
The above data indicate that SEIPIN interacts with GPAT to
inhibit its activity. Although the immediate product of GPAT
catalysis is lysophosphatidic acid, GPAT is the rate-limiting
step, and the next enzyme in this synthetic pathway, lyso-
phosphatidic acyltransferase, rapidly converts lysophosphati-
dic acid (LPA) to PA. Thus, increasing GPAT activity increases
the level of PA in mammalian cells (Zhang et al., 2012a, 2014).
In yeast, elevated PA in the ER is associated with the forma-
tion of ‘‘supersized’’ LDs in fld1 null cells (Fei et al., 2011c),
which had higher GPAT activity (Figures 3 and S4G–S4J).
Is the increase in GPAT activity sufficient to raise the
amount of PA on the ER and drive the formation of supersized
LDs? Indeed, overexpressing wild-type, but not ‘‘catalytically
dead,’’ GAT1 and GAT2 in yeast cells caused supersized
LDs to form (Figures 4A and S5A), phenocopying fld1 null
cells. The level of PA in the ER was higher in these cells,
similar to fld1 null cells, as indicated by increased INO1
expression (Figure S5B) (Loewen et al., 2004). As detected
by mass spectrometry, overexpression of GAT2 increased
microsomal PA (Figure 4B). Importantly, when either GAT1
or GAT2 was co-expressed with FLD1, the amount of PA in
the ER was reduced and few supersized LDs were detected
(Figures 4A, 4B, and S5B). These results suggest that loss of
Fld1 increases GPAT activity and the level of PA in the ER,
causing the formation of supersized LDs.
Supersized LDs are also present in SEIPIN-deficient mature
adipocytes and testes, tissues in which SEIPIN is normally highly
expressed (Jiang et al., 2014; Liu et al., 2014). Overexpressing
both GPAT3 and GPAT4 in 3T3-L1 preadipocytes increased
microsomal PA and formed enlarged LDs (Figures 4C–4E and
S5C), but as in yeast, overexpressing SEIPIN together with
GPAT3 and GPAT4 reduced LD size andmicrosomal PA (Figures
4C–4E). Moreover, knocking down Seipin/Bscl2 in 3T3 L1 prea-
dipocytes increased the size of LDs, a feature that was reversed
by knocking down either Gpat3 orGpat4 (Figures S5D and S5E).
In Huh7 cells, where there is little SEIPIN expression, over-
expressing GPAT3 or GPAT4 alone can dramatically increase
LD size (Figure S5F). To further investigate the functional rela-
tionship between SEIPIN and GPAT at system level, we exam-
ined the morphology of the larval salivary gland of Drosophila.
Numerous globular structures are present in dSeipin mutants
(Figure 5A) (Tian et al., 2011), and these structures can be en-
circled by a lipid droplet surface marker PLIN1-mCherry (Fig-
ure 5B), indicating that they are lipid droplets. GPAT (Drosophila
gene CG5508) overexpression results in large lipid droplets
similar to dSeipin mutants (Figure 5C), while overexpressing
AGPAT (CG17608), Lipin (CG8709), or DGAT (CG31991) using
AB
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Figure 2. Mammalian SEIPIN and GPAT3/4 Physically Interact
(A) Co-immunoprecipitation by FLAG and hemagglutinin (HA) antibody of overexpressed FLAG-tagged GPAT3 or GPAT4 and HA-tagged SEIPIN, respectively,
from transfected 3T3-L1 cell lysates.
(B and C) Immunoblotting for overexpressed HA-tagged mutant or wild-type SEIPIN and FLAG-tagged GPAT3 and GPAT4, respectively, after HA-immuno-
precipitation from 3T3-L1 cells. See also Figure S2.
(D) Endogenous GPAT4 and GPAT3 proteins co-immunoprecipitate with overexpressed SEIPIN from 3T3-L1 adipocytes stably transfected with HA- or FLAG-
SEIPIN.
(E) 3T3-L1 adipocytes expressing FLAG-SEIPIN, FLAG-tagged biotin ligase BirA*, or FLAG-tagged BirA*-SEIPIN were treated with 50 mM biotin for 24 hr. The
biotinylated proteins were pulled down using streptavidin-conjugated agarose from biological duplicates. Elutes were subjected to western blot analysis. All
experiments were performed in triplicate.
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Figure 3. GPAT Activity Is Significantly Increased and GPAT Kinetics Are Altered in SEIPIN-Deficient Cells and Tissues
(A–D) GPAT specific activity (initial rates) was measured in total membrane preparations from (A) BY4741 and fld1D yeast, (B) control and Bscl2/
mouse embryonic fibroblasts, (C) control and shBSCL2 3T3L1 preadipocytes, and (D) control and Bscl2/ testes. Membrane proteins were incubated
on ice for 15 min in the presence or absence of 2 mM NEM. Experiments were performed in triplicate. Data are presented as mean ± SEM. See also
Figure S4.
(E–H) GPAT dependence on glycerol-3-phosphate or Palmitoyl-CoA in control and Bscl2/ testis (E and F) and control and shBSCL2 3T3-L1 preadipocytes (G
and H). Glycerol-3-phosphate and palmitoyl-CoA concentrations were varied as indicated. Double-reciprocal plots are shown in Figures S4G–S4J. All experi-
ments were performed in triplicate. Data are presented as mean ± SEM.
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Figure 4. Increased GPAT Activity Under-
pins the Change in LD Morphology in
SEIPIN-Deficient Cells
(A) Nile-red-stained lipid droplets of BY4741 wild-
type (WT), fld1D, GAT1-, or GAT2-overexpressing
strains (O/E Gat1 and O/E Gat2), strains over-
expressing catalytically dead gat mutants (O/E
Gat1 G262D and O/E Gat2 G253L), and double-
transformed strains (O/E Gat1 + O/E Fld1 and O/E
Gat2 + Fld1). The cells were grown to early sta-
tionary phase.
(B and E) Lipidomic analysis of microsomal PA in
the indicated yeast strains and transduced pre-
adipocytes. Phospholipids were extracted from
cells, subjected to HPLC MS/MS, and analyzed
using Lipid Search software. n = 4. *p < 0.05;
**p < 0.01; ***p < 0.001.
(C) BODIPY-stained lipid droplets in 3T3-L1 pre-
adipocytes, transduced with indicated lentiviral
expression vectors and incubated with 400 mM
oleate for 16 hr. Representative confocal images
are shown.
(D) Diameters of top three largest lipid droplets in
100 of each cell line were measured to determine
the droplet volumes. Data represent mean ± SD
(****p < 0.0001).
See also Figure S5.the same promoter leads to many tiny lipid droplets. ACAT
(CG8112) overexpression forms small lipid droplets and aber-
rant patch-like structures. Finally, knocking down dSEIPIN in
Drosophila S2 cells increased LD size, which was suppressed
by knocking down GPAT simultaneously (Figure 5D). Together,
these results strongly suggest that increased GPAT activity un-
derpins the formation of supersized LDs in SEIPIN-deficient cells
and tissues.Cell ReporDuring Early Differentiation, SEIPIN
Alters GPAT Kinetics
In addition to its role in modulating LD
expansion, SEIPIN is required for
normal adipogenesis. Loss of Seipin
disrupts adipogenesis within the first
few hours of differentiation (Chen
et al., 2012; Payne et al., 2008). We
asked whether this feature was also
related to SEIPIN’s ability to regulate
GPAT activity and PA metabolism. We
first examined whether the level of PA
is disturbed in Seipin knockdown 3T3-
L1 preadipocytes by mass spectrom-
etry. As shown in Figures 6A and 6B,
total microsomal PA and the majority
of PA species were significantly
increased upon SEIPIN depletion. We
then examined GPAT kinetics during
the differentiation of 3T3L1 preadipo-
cytes. In wild-type (WT) cells, the
apparent KM values for glycerol-3-P af-
ter 0, 4, 8 and 12 hr of differentiationwere 176, 267, 176, and 153 mM, respectively (Figure S6A),
consistent with a transient drop in affinity for glycerol-3-P at
4 hr. In contrast, the apparent KM values for glycerol-3-P in
Seipin knockdown cells at the same time points were 113,
147, 142, and 138 mM, respectively, values considerably lower
than in the control cells (Figures S6B and S6C). These findings
suggest the possibility that SEIPIN regulates GPAT kinetics
early during differentiation to regulate PA homeostasis.ts 17, 1546–1559, November 1, 2016 1551
Figure 5. SEIPIN and GPAT Functionally Interact in Drosophila
(A–C) GPAT overexpression results in large lipid droplets similar to dSeipinmutants in the salivary gland of Drosophila. (A) Differential interference contrast (DIC)
image of wild-type and dSeipinmutant larval salivary gland. Scale bar, 100 mm. (B) The largest lipid droplets in dSeipin mutants can be encircled by lipid droplet
surface marker PLIN1-mCherry. The genotype is dSeipin; ppl-Gal4>UAS-PLIN1-mCherry. Scale bar, 50 mm. (C) DIC images of third-instar larval salivary gland of
different genotypes. GPAT (Drosophila gene CG5508), AGPAT (CG17608), Lipin (CG8709), DGAT (CG31991), and ACAT (CG8112) were each overexpressed
using the ppl-Gal4 promoter. Scale bar, 50 mm.
(D) RNAi-mediated knockdown of SEIPIN in Drosophila S2 cells increases LD size, which can be suppressed by simultaneously knocking down GPAT.
Representative confocal images of RNAi-treated and BODIPY-stained cells are shown. Scale bar, 10 mm. Statistical testing utilized one-way ANOVA with a post-
Tukey’s multiple comparison test. Error bars represent ± SEM. ***p < 0.001.Increased GPAT3 Activity Impairs Adipogenesis in
SEIPIN-Deficient Cells
If SEIPIN deficiency increases GPAT activity sufficiently to
block adipogenesis, then reducing GPAT in SEIPIN-deficient
cells should be able to restore adipogenesis. As predicted, in
Seipin-deficient 3T3L1 preadipocytes, knocking down Gpat3,1552 Cell Reports 17, 1546–1559, November 1, 2016but not Gpat4, significantly enhanced adipocyte differentiation
(Figures 6C, 6D, S6D, and S7A–S7E). Finally, to determine
whether the increased GPAT activity is sufficient to block adipo-
cyte differentiation, we overexpressed Gpat3 or Gpat4 in 3T3L1
preadipocytes. Overexpression of Gpat3 blocked adipogenesis
(Figures S7F–S7H), whereas overexpressing Gpat4 had only a
AB
C
D
Figure 6. Increased GPAT3 Activity Impairs Adipogenesis in SEIPIN-Deficient Preadipocytes
(A and B) Lipidomic analysis of microsomal PA in control and shBSCL2 3T3L1 preadipocytes. Phospholipids were extracted from cells, subjected to HPLC MS/
MS, and analyzed using Lipid Search software. n = 4. *p < 0.05; **p < 0.01; ***p < 0.001.
(C) Oil red O stains of differentiated/undifferentiated 3T3-L1 cells stably transfected with the indicated lentiviral knockdown vectors.
(D) Pparg, aP2 andC/ebpamRNA levels were measured by qRT-PCR in 3T3-L1 cells transduced with the indicated lentiviral knockdown vectors at the indicated
time points after induction of differentiation. All experiments were performed in triplicate. See also Figures S6 and S7.
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moderate inhibitory effect on adipogenesis (data not shown).
Importantly, the simultaneous overexpression of Seipin and
Gpat3 restored normal differentiation (Figure S7F–S7H). Taken
together, these findings strongly support the interpretation that
increased GPAT activity underlies the block in adipogenesis in
Seipin-deficient cells.
GPAT Inhibitor Partially Rescues the Differentiation of
Seipin/ Preadipocytes
Our results above strongly suggest that pharmacological
inhibition of GPAT activity may also restore the differentiation
of SEIPIN-deficient cells. Thus, we isolated primary preadipo-
cytes from control and Seipin-deficient mice and differentiated
them in the presence or absence of a GPAT inhibitor (formula:
C21H26CINO4S) (Outlaw et al., 2014; Wydysh et al., 2009).
The inhibition was competitive for NEM-sensitive (microsomal)
and NEM-resistant (mitochondrial) GPAT activities (Figure 7A).
Inhibition of GPAT at 40 mM increased the number of cells posi-
tively stained with Oil red O, as well as the expression of adipo-
genesis marker genes in Seipin/ cells (Figures 7B and 7C).
DISCUSSION
SEIPIN’s role in mammalian lipid storage is unique, because it
regulates both adipocyte differentiation and the expansion of
cellular LDs (Fei et al., 2011a). However, as an integral membrane
protein of the ER without known functional domains, SEIPIN’s
mechanism of action has been difficult to understand. Here, we
demonstrate that SEIPIN and its yeast ortholog, Fld1, can interact
specifically with the ER-located GPAT isoforms and that this
evolutionarily conserved interaction diminishes the specific activ-
ity of both yeast and mammalian GPAT isoforms and alters their
substrate affinities. Our data provide strong evidence that when
SEIPIN is absent, enhanced microsomal GPAT activity results in
defective adipogenesis and altered LD morphology.
The acylation of glycerol-3-P, catalyzed by GPAT, is the initial
and rate-limiting step in the synthesis of triacylglycerol and the
glycerophospholipids. The mitochondrial isoform GPAT1 con-
tributes between 20% and 50% of the total GPAT activity in liver
but only 10% of total GPAT activity in other tissue types (Cole-
man and Mashek, 2011). A second mitochondrial GPAT isoform,
GPAT2, is expressed primarily in testes. The microsomal GPAT
isoforms, GPAT3 and GPAT4, have an 80% amino acid identity
and, like the two Gat isoforms in yeast, are integral membrane
proteins of the ER (Marr et al., 2012) but maymove to the surface
of LDs during LD expansion (Wilfling et al., 2013). Similarly, yeast
Gat1 may be present on LDs during the stationary phase of yeast
growth (Marr et al., 2012). Insulin increases the activities of
mammalian GPAT3 and GPAT4 by phosphorylation at Ser and
Thr residues, although the functional outcome of thesemodifica-
tions is unclear (Shan et al., 2010). Overall, the regulation of the
ER GPATs remains largely unexplored, and no GPAT-interacting
proteins have previously been identified.
Through a non-biased screen in yeast, we identified the yeast
GPAT, Gat1, as a potential interacting partner of the yeast
SEIPIN ortholog, Fld1. Multiple lines of evidence support a spe-
cific physical association between orthologs of SEIPIN and ER
GPATs. Yeast and mammalian SEIPIN were co-immunoprecipi-1554 Cell Reports 17, 1546–1559, November 1, 2016tatedwith their respective yeast andmammalian GPAT orthologs,
and both biotinylation and proximity ligation assays confirmed the
close proximity of SEIPIN and GPAT3/4. Interestingly, compared
to wild-type SEIPIN, the disease-causing missense mutant T78A
had a weakened association with GPAT3/4. These data strongly
support a specific physical association between SEIPIN and
GPAT3/4. However, because both SEIPIN and the ER GPATs
are integral membrane proteins that have resisted purification,
we are unable to determine their stoichiometry in vitro or whether
their interaction is direct. Because SEIPIN forms oligomers (Sim
et al., 2013; Binns et al., 2010; Fei et al., 2011b), it is possible
that a single GPAT3/4 molecule may interact with a SEIPIN olig-
omer. Moreover, whether SEIPIN missense mutants such as
T78A cause lipodystrophies through reduced interaction with
GPAT remains inconclusive, and future studies will focus on this
aspect.
The specific link between orthologs of SEIPIN and the ER
GPAT isoforms was strongly and consistently supported by
functional assays. SEIPIN deficiency is associatedwith two strik-
ing phenotypes: (1) a near complete block in adipogenesis and
(2) the enlargement of LDs in yeast and in those mammalian cells
and tissues in which SEIPIN is normally highly expressed, such
as testes and mature adipocytes (Liu et al., 2014; Jiang et al.,
2014). SEIPIN’s association with the ER GPAT isoforms can
explain its roles in adipogenesis and LD expansion. As illustrated
in Figure S8, our data support the hypothesis that when SEIPIN
interacts with the ER GPATs, their enzymatic activity is reduced
and the production of PA is diminished. Thus, the normal interac-
tion of SEIPIN and the ER GPAT isoforms results in two major
consequences: (1) because PA inhibits PPARg, low GPAT activ-
ity during the first few hours of adipocyte differentiation permits
PPARg to be fully active, so that normal adipogenesis can
proceed; and (2) in mature adipocytes, yeast, and other cells,
SEIPIN-regulated ER GPAT activity controls the size of LDs,
possibly by limiting the amount of fusogenic PA (Figure S7).
Conversely, in the absence of SEIPIN, ER GPAT-specific activity
is enhanced and PA production increases. The high PA concen-
tration may inhibit PPARg activity or other signaling pathways in
preadipocytes, thereby blocking adipogenesis (Stapleton et al.,
2011; Zhang et al., 2012b; Nadra et al., 2012). In other cells,
the absence of SEIPIN also results in high GPAT activity and
increased local production of PA at the ER, resulting in aberrant
LD budding and growth and the formation of supersized LDs (Fei
et al., 2011c). Several critical experiments support this inter-
pretation, including the alteredGPAT kinetics whenSEIPIN is ab-
sent, the near-normal adipocyte differentiation that occurs when
both SEIPIN and GPAT3 are absent, the formation of supersized
LDswhen the ERGPATs are overexpressed, and the reduction in
LD size when SEIPIN and GPAT are co-expressed.
SEIPIN has been reported to interact with two other glyceroli-
pid synthetic enzymes, AGPAT2 and LIPIN1 (Talukder et al.,
2015; Sim et al., 2012). However, there is a fundamental differ-
ence between those studies and ours. SEIPIN was proposed
to facilitate AGPAT2 and LIPIN1 function, whereas our data sug-
gest that SEIPIN inhibits GPATs. Moreover, although the interac-
tion of SEIPIN with AGPAT2 and LIPIN1 is relevant for the meta-
bolism of PA, GPAT is recognized as the rate-limiting enzyme in
the pathway. Importantly, the notion that SEIPIN anchors and
AB
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facilitates LIPIN function overlooks existing physiological evi-
dence (Talukder et al., 2015). For example, depleting lipin-1 in
mouse adipocytes reduces the size of LDs, whereas depleting
Seipin in mouse adipocytes increases LD size (Nadra et al.,
2012; Liu et al., 2014). Furthermore, our co-immunoprecipitation
study in yeast could not detect a SEIPIN-LIPIN1 interaction (data
not shown), and the yeast AGPAT2 homolog, Slc4, did not co-
precipitate well with Fld1. Importantly, when overexpressed in
the salivary gland of Drosophila under the same promoter,
GPAT is the only enzyme that gave rise to supersized LDs.
InDrosophila, SEIPIN has been reported to interact with sarco/
endoplasmic reticulum calciumATPase (SERCA), an ER-specific
calcium pump (Bi et al., 2014). However, alterations in ER fatty
acid and lipid composition are known to inhibit SERCA activity
(Fu et al., 2011). Because our results support a primary function
of SEIPIN in ER phospholipid metabolism, the disrupted calcium
homeostasis observed in SEIPIN-deficient cells may be second-
ary to an altered ER phospholipid composition. Recent data also
suggest that SEIPIN is involved in the vectorial export of TAG
from the ER or the stabilization of ER-LD contact sites (Cart-
wright et al., 2015; Grippa et al., 2015). Our findings described
here do not necessarily contradict with those observations;
changes in PA concentration/localization of the ER may also
impact the vectorial budding of droplets and/or the phospholipid
composition of LDs (Wolinski et al., 2015; Han et al., 2015).
Although both GPAT3 and GPAT4 can interact with SEIPIN,
they exhibited clear functional differences. Overexpressing either
enzyme altered LD morphology at least in Huh7 cells, but only
GPAT3 appeared to play a major role in adipogenesis (Shan
et al., 2010). Surprisingly, although GPAT3 is highly upregulated
in differentiating adipocytes,Gpat3/mice had relativelymodest
phenotypic alterations, and decreased weight gain was detected
only when Gpat3/ mice were fed a high-fat diet (Cao et al.,
2014). GPAT4 is moderately upregulated during adipogenesis,
but it is the major microsomal GPAT activity in brown adipose tis-
sue, where its presence is required to limit the oxidation of exog-
enous fatty acids (Cooper et al., 2015). Murine GPAT4 is known to
localize to LDs (Wilfling et al., 2013); however, our data suggest
that both ER GPATs can localize to LDs, particularly GPAT3.
Taken as a whole, our data provide strong evidence that
SEIPIN interacts with and regulates ER GPATs in mammalian
cells, fly, and S. cerevisiae. This is the first example of an evolu-
tionarily conserved, physiological regulator of the ER GPATs.
EXPERIMENTAL PROCEDURES
Materials
Strains, primers, plasmids, and antibodies are listed in Tables S3–S7. [3H]
Glycerol-3-P was synthesized enzymatically (Chang and Kennedy, 1967).Figure 7. GPAT Inhibitor Can Partially Rescue the Differentiation of Se
(A) Glycerol-3-phosphate dependence of GPAT was determined by incubating 1
concentration of G3P from 10 to 800 mM, in the absence or presence of NEM. All e
See also Figure S6.
(B) The recovery of differentiation (day 8) is shown byOil red O staining ofWT,Bscl
of differentiation.
(C) Total RNA extracted from wild-type and Seipin/ preadipocytes cultured in t
mRNA levels by qPCR. Values represent mean ± SD of three independent experim
t test. *p < 0.05, inhibitor treatment versus DMSO in Seipin KO cells.
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Wild-type yeast cells transformed with plasmid pLacYCP-GFP and fld1D cells
transformed with pLacYCP-Fld1-GFP were grown to early stationary phase
and then lysed using a bead beater in three different buffers: buffer 1
(25 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5% Triton X-100, 0.2 mM EDTA,
and 0.2 mM DTT), buffer 2 (20 mM K-HEPES [pH 7.4], 110 mM CH3CO2K,
150 mM NaCl, 0.1% Triton X-100, 0.1% Tween 20, and 2 mM MgCl2), and
buffer 3 (20 mM K-HEPES [pH 7.4], 110 mM CH3CO2K, 150 mM NaCl, 0.1%
Triton X-100, 0.1% Tween 20, 46 mM n-octyl-B-D-glucopyranoside, 2 mM
MgCl2, and 5% glycerol). Cell lysates were initially incubated with Sepharose
CL-4B (GE Healthcare) to pull down proteins interacting with beads, and the
supernatants were affinity purified using a GFP-Trap (ChromoTek) (Rothbauer
et al., 2008) to pull down proteins interacting with GFP and Fld1-GFP,
respectively.
Identification of Fld1-Interacting Candidates
Proteins were eluted from Sepharose and GFP-Trap beads with a low-pH
buffer (pH 2) containing 100 mM glycine, neutralized, and separated on
4%–15% Tris-HCl gels (Bio-Rad). After staining with Coomassie brilliant
blue R-250 (Sigma), protein bands were digested in-gel with trypsin (Shev-
chenko et al., 1996), and the sequences of the resultant peptides were deter-
mined by liquid chromatography tandem mass spectrometry using LTQ-Orbi-
trap Velos Pro (Thermo Fisher Scientific) coupled to UltiMate 3000 RSLC
(Dionex). A list of candidate interactors was created from proteins identified
in at least three Fld1-GFP pull-downs and absent in the controls (Table S1).
Proteins were identified by at least two unique unmodified peptides with a
score of 20.
Yeast Growth
Yeast cells were grown as described previously (Sherman, 2002).
Mammalian Cell Culture
HeLa, MEF, 3T3-L1, HEK293FT, and Phoenix Eco cells were grown in DMEM,
10% fetal bovine serum (FBS) (Invitrogen), and 100 U/mL penicillin and strep-
tomycin. Cells were transiently transfected with plasmids using Lipofectamine
LTX/Plus (Invitrogen). To induce triacylglycerol synthesis and LD formation,
cells were incubated for 16 hr with 400 or 800 mM BSA-coupled oleate.
Retro- and Lentivirus Production and Stable Cell Line Generation
pLKO.1-based shRNA lentiviral or pBABE-based retroviral expression con-
structs (Table S6) were used to generate lentivirus in HEK293T cells or retro-
virus in Phoenix Eco cells, respectively. 3T3-L1 cells were incubated for
24 hr with lenti- or retrovirus together with 8 mg/mL polybrene. Stable cells
were selected with 4 mg/mL puromycin and/or 800 mg/mL neomycin for
10 days before use or storage in liquid N2.
Adipocyte culture and differentiation and qRT-PCR were carried out as
described previously (Chen et al., 2012; Payne et al., 2008).
Pre-adipocyte Isolation and Differentiation
Animal protocols were approved by the University of North Carolina at Chapel
Hill Institutional Animal Care and Use Committee. Mouse preadipocytes were
isolated from gonadal adipose tissue. After excising blood vessels, adipose
tissue was minced into small pieces, decanted into isolation medium
(DMEM supplemented with 25 mM HEPES, 2% BSA, and 2 mg/mL collage-
nase), and digested for 30min at 37Cwith constant shaking. Suspended cellsipin/ Preadipocytes
0–20 mg total particulate in the presence of 82.5 mM 16:0 CoA and varying the
xperiments were performed in triplicates. Data are presented as mean ± SEM.
2KO, andBscl2KOMEF cells treatedwith 40 mM inhibitor during the first 2 days
he presence or absence of GPAT inhibitor was used to measure the indicated
ents performed in triplicate. Statistical analysis was performed using Student’s
were then filtered through a 100-mm nylon filter, centrifuged for 5 min at 4003
g, and resuspended in DMEM supplemented with 10% newborn calf serum
and 100 U/mL penicillin and streptomycin. Differentiation was carried out as
described above, and the GPAT inhibitor was present during the first 48 hr
of differentiation.
GPAT Activity and Kinetics
The right testis or MEFs and 3T3L1 cells from 10-cm dishes were homog-
enized in cold medium I (250 mM sucrose, 10 mM Tris [pH 7.4], 1 mM
EDTA, 1 mM DTT) using 10 up-and-down strokes with a Teflon-glass mo-
tor-driven homogenizer. Total membranes were isolated by centrifuging
the homogenate at 100,000 3 g for 1 hr. GPAT specific activity (initial rates)
was assayed for 10 min at room temperature (RT) in a 200 mL reaction
mixture containing 75 mM Tris-HCl (pH 7.5), 4 mM MgCl2, 1 mg/mL BSA
(essentially fatty-acid-free), 1 mM DTT, 8 mM NaF, 800 mM [3H]glycerol-
3-P, and 82.5 mM palmitoyl-CoA. Membrane protein was incubated on
ice for 15 min in the presence or absence of 2 mM NEM, which inactivates
GPAT isoforms 2, 3, and 4 (Lewin et al., 2004). The reaction was initiated by
adding 20 mg (testis), 15 mg (MEFs), or 5 mg (3T3L1) of membrane protein.
Reaction products were extracted into 2 mL CHCl3. NEM-resistant activity
(GPAT1) was calculated by subtracting NEM-sensitive activity from total
activity. To determine the reaction products, 1 mL of the CHCl3 extract
was dried under N2, resuspended in 30 mL CHCl3:CH3OH (2:1; v/v), and
separated by thin-layer chromatography (CHCl3:pyridine:88% formic acid,
50:30:7; v/v). More than 90% of the reaction product was PA, and the
remainder was lysophosphatidic acid. [3H]Glycerol-3-P concentrations
(40–400 mM) or palmitoyl-CoA concentrations (11.25–150 mM) were varied
to analyze enzyme kinetics.
BY4741 and fld1D cells were collected by centrifuging at 3,0003 g for 5 min,
rinsed twice in dH2O, and stored at80Cuntil further use. To obtain totalmem-
brane fractions, yeast cells were resuspended in 1mL zymolyase buffer (50mM
potassium phosphate [pH 7.5], 10 mM b-mercaptoethanol) containing 1,000 U
zymolyase (Zymo Research). Cell suspensions were shaken at 150 rpm at 30C
for 90 min. The supernatant was then homogenized, and membranes were
isolated by centrifugation as described above. To assay GPAT activity in yeast,
20 mg membrane protein was pre-incubated in the presence of 50 mM 16:0 CoA
for 1 hr. Reactions were initiated by adding the [3H] glycerol-3-phosphate. To
analyze enzyme kinetics in yeast, [3H] glycerol-3-P concentrations (5–400 mM)
or palmitoyl-CoA concentrations (12.5–100 mM) were varied.
Co-immunoprecipitation and Western Blotting
Antibodies used are listed in Table S8. Yeast cell lysates were prepared as
described previously (Fei et al., 2008). 2 mg protein was used for each co-
immunoprecipitation condition. Antibody was immobilized on magnetic
Dynabeads (Dynabeads Co-Immunoprecipitation Kit manual). After 30 min
of incubation with the cell lysates containing overexpressed protein at RT, or
after overnight incubation with the cell lysates containing low levels of
recombinant protein at 4C, beads were washed and eluted at 37C for
20 min. Proteins were transferred onto polyvinylidene fluoride (PVDF) mem-
branes, followed by immunodetection (Fei et al., 2008).
Transiently or stably transfected mammalian cells (MEFs, mouse 3T3-
L1preadipocytes, and HeLa cells) were washed three times with ice-cold
PBS and lysed in immunoprecipitation (IP) lysis/wash buffer (as above) con-
taining 1% (w/v) n-dodecyl-b-D-maltopyranoside (DDM; Sigma) by forcing
the cells 30 times through a 0.8-mm needle. Immunoprecipitation and western
blotting were carried out as described above.
BirA* Pull-Down Assays
The cDNA for BirA* was subcloned from pGEM-SD2-BirA* (a kind gift of
John Strouboulis, Erasmus University Medical Center, Rotterdam, the
Netherlands). 3T3-L1 preadipocytes were transduced with FLAG-tagged
SEIPIN, FLAG-tagged biotin ligase BirA*, or FLAG-tagged BirA*-SEIPIN
delivered using retrovirus, and cells were then induced to differentiate to
mature adipocytes. On day 8 of differentiation, cells were treated with
50 mM biotin for 24 hr and then lysed. Cell lysates were precleared with
empty protein G agarose beads for 4 hr and then incubated with streptavi-
din-conjugated agarose for 2 hr at room temperature. The beads werecollected and washed with buffers as described previously (Roux et al.,
2012), incubated with sample buffer containing 1.5 mM biotin, and heated
for 1 hr at 65C before western blot analysis.
Proximity Ligation Assay
HeLa cells transfected with indicated plasmids were fixedwith 4%paraformal-
dehyde (Electron Microscopy Sciences) for 15 min and permeabilized with
0.2% Triton X-100 (Sigma-Aldrich) for 10 min at room temperature. Cells
were then blockedwith 3%BSA in PBS for 1 hr and incubated with appropriate
combinations of mouse anti-FLAG (1:100; Clontech Laboratories) and rabbit
anti-HA (1:3,000; CST) antibodies diluted in blocking solution for 1 hr at
room temperature. This was followed by proximity ligation assay using the Du-
olink detection reagent kit (Olink Bioscience) according to the manufacturer’s
protocol. Fluorescence images were acquired using an Olympus Fluoview
FV1200 confocal microscope with a 603/1.35 UPlanSApo objective. Images
were prepared and analyzed with Fiji software (http://fiji.sc). For each experi-
ment, signals from at least 50 cells were quantified. All data were analyzed
using GraphPad PRISM software.
Fluorescence Microscopy
Yeast cells were stained with 20 mg/mL Nile red (Sigma-Aldrich). For mamma-
lian lipid droplets, BODIPY 493/503 (Invitrogen) was used. Imaging was
performed using a Leica SP5 confocal microscope and a Leica HCX 633
1.4 numerical aperture objective.
Lipidomic Analysis of Microsomal PA
Phospholipids were extracted from microsomes isolated from yeast or
mammalian cells, subjected to high performance liquid chromatography
(HPLC) tandem mass spectrometry (MS/MS) and analyzed using Lipid Search
software as described (Qi et al., 2016; Fei et al., 2011c).
Drosophila experiments are as described previously (Tian et al., 2011). ppl-
Gal4 was used to drive the overexpression of genes indicated.
Statistics
Experiments were performed in triplicate. The results are presented as
mean ± SD. Two-tailed Student’s t test was used for comparison.
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